Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q34591821)
Watch
English
A review of the use of adapalene for the treatment of acne vulgaris
scientific article
In more languages
default values for all languages
No label defined
No description defined
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PMC publication ID
2374937
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18472984%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 January 2020
review article
1 reference
stated in
Europe PubMed Central
title
A review of the use of adapalene for the treatment of acne vulgaris
(English)
1 reference
stated in
Europe PubMed Central
PMC publication ID
2374937
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18472984%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 January 2020
author
Suleyman Piskin
series ordinal
1
1 reference
stated in
Europe PubMed Central
PMC publication ID
2374937
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18472984%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 January 2020
author name string
Erol Uzunali
series ordinal
2
1 reference
stated in
Europe PubMed Central
PMC publication ID
2374937
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18472984%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 January 2020
publication date
1 August 2007
1 reference
stated in
Europe PubMed Central
PMC publication ID
2374937
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18472984%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 January 2020
published in
Therapeutics and Clinical Risk Management
1 reference
stated in
Europe PubMed Central
PMC publication ID
2374937
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18472984%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 January 2020
volume
3
1 reference
stated in
Europe PubMed Central
PMC publication ID
2374937
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18472984%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 January 2020
issue
4
1 reference
stated in
Europe PubMed Central
PMC publication ID
2374937
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18472984%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 January 2020
page(s)
621-624
1 reference
stated in
Europe PubMed Central
PMC publication ID
2374937
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18472984%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 January 2020
cites work
Adapalene gel, 0.1%, as maintenance therapy for acne vulgaris: a randomized, controlled, investigator-blind follow-up of a recent combination study
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374937
retrieved
7 July 2018
A successful maintenance approach in inflammatory acne with adapalene gel 0.1% after an initial treatment in combination with clindamycin topical solution 1% or after monotherapy with clindamycin topical solution 1%.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374937
retrieved
7 July 2018
Optimizing treatment with topical tazarotene
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374937
retrieved
7 July 2018
Comedogenesis: some aetiological, clinical and therapeutic strategies
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374937
retrieved
7 July 2018
Acne vulgaris, II: treatment
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374937
retrieved
7 July 2018
Successful treatment of acne vulgaris using a new method: results of a randomized vehicle-controlled trial of short-contact therapy with 0.1% tazarotene gel.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374937
retrieved
7 July 2018
Adapalene biochemistry and the evolution of a new topical retinoid for treatment of acne
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374937
retrieved
7 July 2018
Adapalene: an update on newer comparative studies between the various retinoids
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374937
retrieved
7 July 2018
The growing importance of topical retinoids in clinical dermatology: a retrospective and prospective analysis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374937
retrieved
7 July 2018
Topical treatment of acne vulgaris: retinoids and cutaneous irritation
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374937
retrieved
7 July 2018
Acne. What every pediatrician should know about treatment
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374937
retrieved
7 July 2018
New understandings of the pathogenesis of acne
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374937
retrieved
7 July 2018
Adapalene gel 0.3% for the treatment of acne vulgaris: a multicenter, randomized, double-blind, controlled, phase III trial
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374937
retrieved
27 October 2018
The efficacy and safety of adapalene gel 0.3% in the treatment of acne vulgaris: A randomized, multicenter, investigator-blinded, controlled comparison study versus adapalene gel 0.1% and vehicle
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374937
retrieved
27 October 2018
Cumulative irritation potential of adapalene 0.1% cream and gel compared with tazarotene cream 0.05% and 0.1%.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374937
retrieved
27 October 2018
Combination therapy with adapalene gel 0.1% and doxycycline for severe acne vulgaris: a multicenter, investigator-blind, randomized, controlled study
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374937
retrieved
27 October 2018
Benzoyl peroxide, adapalene, and their combination in the treatment of acne vulgaris.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374937
retrieved
27 October 2018
Single‐blind and comparative clinical study of the efficacy and safety of benzoyl peroxide 4% gel (BID) and adapalene 0.1% Gel (QD) in the treatment of acne vulgaris for 11 weeks
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374937
retrieved
27 October 2018
Cumulative irritancy comparison of adapalene gel 0.1% versus other retinoid products when applied in combination with topical antimicrobial agents
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374937
retrieved
27 October 2018
A comparative trial of two retinoids commonly used in the treatment of acne vulgaris
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374937
retrieved
27 October 2018
Topical adapalene gel 0.1% vs. isotretinoin gel 0.05% in the treatment of acne vulgaris: a randomized open-label clinical trial
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374937
retrieved
27 October 2018
Randomized controlled trial of the tolerability, safety, and efficacy of adapalene gel 0.1% and tretinoin microsphere gel 0.1% for the treatment of acne vulgaris.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374937
retrieved
27 October 2018
Comparison of adapalene 0.1% solution and tretinoin 0.025% gel in the topical treatment of acne vulgaris.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374937
retrieved
27 October 2018
Clinical efficacy and safety comparison of adapalene gel and tretinoin gel in the treatment of acne vulgaris: Europe and U.S. multicenter trials.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374937
retrieved
27 October 2018
Evaluation of clinical efficacy and safety of adapalene 0·1% gel versus tretinoin 0·025% gel in the treatment of acne vulgaris, with particular reference to the onset of action and impact on quality of life
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/18472984
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
A comparison of the efficacy and tolerability of adapalene 0.1% gel versus tretinoin 0.025% gel in patients with acne vulgaris: a meta-analysis of five randomized trials
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/18472984
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Topical delivery system for tretinoin: research and clinical implications
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/18472984
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Identifiers
PMC publication ID
2374937
1 reference
stated in
Europe PubMed Central
PMC publication ID
2374937
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18472984%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 January 2020
PubMed publication ID
18472984
1 reference
stated in
Europe PubMed Central
PMC publication ID
2374937
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18472984%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 January 2020
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit